ESR1 and breast carcinoma: CBP/P300 acetylates histone H3K27 to increase the transcription of CPT1A, thereby increasing FAO and mitigating the cytotoxic effects of tamoxifen in estrogen receptor (ER) + breast cancer cells [193].